WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Ownership - Who owns Viking Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viking Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew W. FoehrDirector2025-04-1120,786$8.00
$166.29kBuy
Sarah Kathryn RouanDirector2025-03-311,240$24.15
$29.94kBuy
Sarah Kathryn RouanDirector2025-03-311,240$24.15
$29.94kBuy
Sarah Kathryn RouanDirector2025-03-311,240$24.15
$29.94kBuy
Marianna ManciniChief Operating Officer2025-01-0649,115$42.69
$2.10MSell
Brian LianPresident CEO2025-01-0619,000$43.32
$823.02kSell
Greg ZanteChief Financial Officer2025-01-064,700$43.32
$203.60kSell
Greg ZanteChief Financial Officer2025-01-0645,609$42.69
$1.95MSell
Marianna ManciniChief Operating Officer2025-01-065,100$43.32
$220.91kSell
Brian LianPresident CEO2025-01-06175,490$42.68
$7.49MSell

1 of 7

VKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VKTX insiders and whales buy or sell their stock.

VKTX Shareholders

What type of owners hold Viking Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.88%16,715,438$467.03MInstitution
Vanguard Group Inc9.06%10,172,441$284.22MInstitution
Blackrock Inc5.23%5,872,978$164.09MInstitution
Ligand Pharmaceuticals Inc5.18%5,819,383$162.59MInsider
State Street Corp4.39%4,925,490$137.62MInstitution
Morgan Stanley2.31%2,593,615$72.47MInstitution
Brian Lian2.11%2,366,570$66.12MInsider
Jpmorgan Chase Co1.92%2,157,543$60.28MInstitution
Geode Capital Management LLC1.67%1,880,713$52.55MInstitution
Citadel Advisors LLC1.32%1,485,079$41.49MInstitution

1 of 3

VKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VKTX72.94%8.96%Net SellingNet Buying
CRSP65.93%34.07%Net SellingNet Selling
MRUS90.15%9.85%Net BuyingNet Buying
SRRK59.72%40.28%Net SellingNet Selling
CRNX88.63%11.37%Net BuyingNet Buying
View Top Biotech Stocks

Viking Therapeutics Stock Ownership FAQ

Who owns Viking Therapeutics?

Viking Therapeutics (NASDAQ: VKTX) is owned by 72.94% institutional shareholders, 8.96% Viking Therapeutics insiders, and 18.10% retail investors. Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder, owning 5.82M shares representing 5.18% of the company. Ligand Pharmaceuticals Inc's Viking Therapeutics shares are currently valued at $168.01M.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.